Talk:Plerixafor
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Plerixafor.
|
Cancer inhibitor
editShould I say "small molecule cancer therapy?" —Preceding unsigned comment added by 165.123.243.168 (talk) 02:13, 13 December 2007 (UTC)
Move
editI propose this page be moved to plerixafor in accordance with WikiProject Pharmacology Naming conventions, as plerixafor is the recommended International Nonproprietary Name: [1].
If there is no objection, I will perform the move in 24 hours. Fvasconcellos 18:40, 24 March 2007 (UTC)
- I have no objection. --Arcadian 19:45, 24 March 2007 (UTC)
- Well, if the article creator doesn't object... :) I'll wait until tomorrow anyway, pro forma. Fvasconcellos 22:50, 24 March 2007 (UTC)
- Move done. Fvasconcellos 02:49, 26 March 2007 (UTC)
How much forms zinc complexes
editWhat % in circulation is singly or doubly complexed with zinc ? (Do typical dosages remove much zinc from patient ? - Why not administer as the zinc complex ? ) - Rod57 (talk) 11:27, 27 October 2015 (UTC)
Research - use with chemo
editAug 2015 Cancer Research : Tested in mice to suppress tumour metastasis caused by some chemo regimens.[citation needed] - Rod57 (talk) 11:27, 27 October 2015 (UTC)